Table of Contents
Ozempic lawsuit eligibility without gastroparesis is one of the most common questions people ask about the GLP-1 litigation. Many assume gastroparesis is the only qualifying injury. That is simply not true. As of May 2026, the federal Ozempic MDL includes claims for multiple serious conditions.
Roughly 25% of the 3,600+ pending cases involve injuries other than gastroparesis. These include pancreatitis, gallbladder disease, bowel obstruction, and vision loss. If you took Ozempic, Wegovy, Mounjaro, or another GLP-1 drug and suffered a serious side effect, ozempic lawsuit eligibility without gastroparesis may apply to you. However, the legal requirements are specific. Understanding ozempic lawsuit eligibility without gastroparesis could protect your right to file before time runs out.
What Injuries Qualify Beyond Gastroparesis in the Ozempic MDL?
The federal Ozempic lawsuit is consolidated as MDL No. 3094 in the U.S. District Court for the Eastern District of Pennsylvania. Judge Karen Spencer Marston oversees the case. She took over after Judge Gene E.K. Pratter passed away in May 2024. A separate MDL (No. 3163) handles vision loss claims. Together, these cases target Novo Nordisk and Eli Lilly for allegedly failing to warn consumers about serious side effects.
When people research ozempic lawsuit eligibility without gastroparesis, they discover a broad list of qualifying injuries. The court accepts claims for ileus (intestinal paralysis), bowel obstruction, acute pancreatitis, gallbladder disease, severe constipation, fecal impaction, acute kidney injury, and pulmonary aspiration during surgery. For example, approximately 18% of current MDL cases involve ileus alone. Another 8% involve gallbladder injuries. These are not rare edge cases.
In January 2025, the FDA updated the Ozempic label to add warnings for acute pancreatitis, necrotizing pancreatitis, ileus, intestinal obstruction, and severe constipation. In March 2026, the FDA cited Novo Nordisk for failing to report three patient deaths linked to the drug. These regulatory actions support ozempic lawsuit eligibility without gastroparesis for a wide range of injuries.
Understanding Ozempic Lawsuit Eligibility Without Gastroparesis
Understanding ozempic lawsuit eligibility without gastroparesis begins with knowing what evidence courts require. Judge Marston set strict evidentiary standards in her August 15, 2025 ruling. For gastroparesis claims specifically, plaintiffs must provide a verified gastric emptying study. CT scans, MRIs, endoscopy results, and symptom-only evidence are not sufficient. However, non-gastroparesis claims follow different evidentiary rules.
For conditions like pancreatitis or gallbladder disease, standard medical records typically suffice. Hospital discharge summaries, surgical reports, and lab results can establish the injury. As a result, some non-gastroparesis claims may actually be simpler to prove. The key factor is timing. You must show your injury occurred after starting a GLP-1 medication and was not caused by a pre-existing condition.
| Qualifying Injury | Evidence Typically Needed | Share of MDL Cases |
|---|---|---|
| Gastroparesis | Gastric emptying study (required by court) | ~75% |
| Ileus / bowel obstruction | Hospital records, imaging | ~18% |
| Gallbladder disease | Surgical records, ultrasound | ~8% |
| Acute pancreatitis | Lab work (lipase/amylase), hospital records | Growing |
| Acute kidney injury | Lab work (creatinine), hospital records | Growing |
| NAION (vision loss) | Ophthalmology records | 86 cases (MDL 3163) |
The litigation also extends to vision loss. MDL No. 3163 covers NAION — non-arteritic anterior ischemic optic neuropathy. This condition causes sudden, often permanent vision loss in one eye. As of May 2026, 86 federal cases are pending. Additional state-level NAION cases are moving forward in New Jersey and Indiana courts.
How to Protect Your Legal Rights Now
Filing deadlines are the biggest threat to ozempic lawsuit eligibility without gastroparesis. Each state sets its own statute of limitations for product liability claims. In most cases, you have two to three years from the date you discovered the injury. However, some states allow far less time. Kentucky, Louisiana, and Tennessee give you only 12 months to file. Missing your state’s deadline means losing your right to sue permanently.
Typically, the clock starts when you knew or should have known your injury was linked to the drug. This is called the “discovery rule.” For example, if you developed pancreatitis in 2024 but did not learn about the Ozempic connection until 2025, your deadline may start from 2025. Courts evaluate this on a case-by-case basis. The rule can work in your favor if the medical link was not widely known at the time of your injury.
To preserve your ozempic lawsuit eligibility without gastroparesis, take these steps now. First, gather all medical records showing your diagnosis, treatment timeline, and hospitalization dates. Second, document your GLP-1 medication history — including start dates, dosages, and prescribing doctors. Third, consult a mass tort attorney before your state’s deadline passes. Bellwether trials are expected in late 2026 or early 2027. No global settlement has been reached yet. As a result, cases filed now will be positioned for the earliest possible resolution.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Frequently Asked Questions
Can I join the Ozempic lawsuit if I had gallbladder surgery but not gastroparesis?
Yes. Ozempic lawsuit eligibility without gastroparesis includes gallbladder disease and cholecystitis. If you needed gallbladder surgery after taking a GLP-1 drug, you may have a valid claim. However, you will need medical records that link the timing of the condition to your use of the medication.
What if my doctor says my side effects are normal for Ozempic?
Common side effects like mild nausea do not qualify for a lawsuit. The litigation requires a serious, documented medical condition. For example, hospitalization, surgery, or a formal diagnosis of pancreatitis or ileus would typically meet the threshold. Mild gastrointestinal discomfort alone is not enough.
How long do I have to file an Ozempic lawsuit?
In most cases, you have two to three years from when you discovered the injury. However, deadlines vary significantly by state. Ozempic lawsuit eligibility without gastroparesis depends on filing before your state’s statute of limitations expires. Kentucky, Louisiana, and Tennessee allow only 12 months, so check your state’s rules immediately.
Check If You Qualify
You may be eligible for compensation from an active lawsuit and not even know it. Use our free tools to find out.
Official Sources & Resources
For verified mass tort and legal information:
- JPML (Case Data): jpml.uscourts.gov
- U.S. Department of Justice: justice.gov
- Cornell Law Institute: law.cornell.edu
- NCSL (State Laws): ncsl.org
- FDA Recalls & Safety: fda.gov
Content last reviewed May 2026. If you notice any outdated information, please contact us.
Related Guides
- Complete Mass Tort Guide
- All Active MDL Cases
- State Tort Reform Laws
- Eligibility Quiz Tool
- Damage Cap Lookup Tool
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.